7th Annual Kentucky Hematology & Oncology Pharmacy Symposium

Lexington, KY US
August 28, 2026

To register, click the “Take Course” button.
Once you click “Take Course,” your enrollment is complete—no additional steps are required. A confirmation email will be sent to the email address associated with your account.

Thank you for registering for the 7th Annual KY Hematology Oncology Pharmacy Symposium. We look forward to seeing you!

The Kentucky Hematology & Oncology Pharmacy Symposium (KHOPS) is hosted by Markey Cancer Network (MCN) and UK Pharmacy Services. This symposium is intended for oncology pharmacists, who are vital members of the cancer care team by helping guide therapy selection and toxicity management, participating in outcomes data analysis, and overseeing pharmacy operations in a rapidly evolving healthcare specialty area. Given the rapidly changing environment, pharmacists must stay informed of advances in practice in order to effectively participate in patient care activities. The purpose of this program is to educate pharmacists regarding the implications of recent innovations in the field of hematology/oncology, as well as provide an opportunity to collaborate with colleagues regarding contemporary challenges in oncology pharmacy.

 

The 2026 Hematology/Oncology Pharmacy Symposium will explore current and emerging topics in oncology pharmacy practice, including:

  • Emerging therapies in hematology and medical oncology
  • Key clinical updates and practice-changing findings from ASCO 2026
  • Formulary management and oncology data trends
  • Integration of Molecular Tumor Boards into oncology pharmacy practice
  • Healthcare policy, regulatory changes, financial toxicity, and medication access challenges
  • Practice innovation, operational excellence, and medication safety
  • Research, quality improvement, and case-based learning to improve patient outcomes

Target Audience

Pharmacists, Physicians, and Nurses in Oncology Care

Learning Objectives

Upon completion of this conference, participants will be able to:

  • Analyze current policies, clinical practice, operations, research, innovations, emerging therapies, and updated guidelines in hematology and oncology.
  • Evaluate the pharmacist's role in medication management, prior authorization processes, and collaborative strategies to optimize patient care and treatment outcomes.
  • Examine contemporary opportunities and challenges in oncology pharmacy through interprofessional collaboration and discussion.
Course summary
Available credit: 
  • 5.25 ACPE

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    This knowledge-based activity will award 5.25 contact hour(s) (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers. Course JA-UAN Number:

  • 5.25 AMA PRA Category 1 Credit™

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    This Live activity is designated for a maximum of 5.25 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity. 

  • 5.25 AMA PRA Category 1 Credit™ Participation

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    This Live activity is designated for a maximum of 5.25 AMA PRA Category 1 Credit™ Participation. Learners should claim only credit commensurate with the extent of their participation in the activity.

  • 5.25 ANCC (UK Healthcare CECentral)

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    The maximum number of hours awarded for this Continuing Nursing Education activity is 5.25 nursing contact hour(s).

  • 5.25 IPCE

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    This activity was planned by and for the healthcare team, and learners will receive 5.25 Interprofessional Continuing Education (IPCE) credit(s) for learning and change.

Course opens: 
07/08/2026
Course expires: 
10/27/2026
Event starts: 
08/28/2026 - 7:30am EDT
Event ends: 
08/28/2026 - 4:00pm EDT
Add to calendar: 
Rating: 
0

Agenda

Friday, August 28, 2026

7:30 – 8:30 a.m. ET

Breakfast, Registration & Networking

8:30 – 8:35 a.m. ET

Welcome & Opening Remarks

Speaker
Philip Schwieterman, PharmD, MHA
University of Kentucky HealthCare

8:35 – 9:20 a.m. ET

General Session 1

My Off-Label Learnings Between Health System and Health Plan

Speaker
Timothy Mok, PharmD, BCPS, BCOP
Manager, Clinical Utilization and Intelligence, Clinic Administered and Specialty Communications (CAMS)
Assistant Clinical Professor
University of California, San Francisco (UCSF) School of Pharmacy

Moderator: Philip Schwieterman, PharmD, MHA

9:20 – 10:05 a.m. ET

General Session 2

2026 ASCO Updates

Speaker
Val Adams, PharmD
Associate Professor, UK College of Pharmacy
Clinical Pharmacist
UK Markey Cancer Center

Moderator: Josh O'Bryan, PharmD

10:05 – 10:30 a.m. ET

Break & Visit Exhibitors

10:30 – 11:15 a.m. ET

General Session 3

Beyond the Green: Navigating Clinical Impacts and Kentucky Cannabis Law

Speakers

Logan Roberts, PharmD, BCPS, BCOP
Hematology Oncology Clinical Pharmacy Specialist
University of Louisville Health
University of Louisville Hospital & Brown Cancer Center

Amy Dawson, PharmD, BCOP
Hematology Oncology Clinical Pharmacist
University of Louisville Health
University of Louisville Hospital & Brown Cancer Center

Moderator: Allison Butts, PharmD

11:15 a.m. – 12:00 p.m. ET

General Session 4

GLP-1 Therapy in Cancer Patients: Current Evidence and Practical Applications

Speakers

Kristina Naseman, PharmD, MPH, BCACP, BC-ADM, CDCES
Pharmacist Coordinator
Diabetes Stewardship PGY2 Ambulatory Care Program Director
Barnstable Brown Diabetes Center

Rachel C. Miller, MS, RD, CSO, LD
Oncology Dietitian
UK Markey Cancer Center

Moderator: Allison Butts, PharmD

12:00 – 1:00 p.m. ET

Lunch & Visit Exhibitors

1:00 – 1:45 p.m. ET

Breakout Session 1

Inhale the Latest: New Horizons in Lung Cancer Drugs

Speaker
Katlyn Mulhall, PharmD, BCOP
Hematology Oncology Pharmacy Specialist
University of Louisville Health
University of Louisville Hospital & Brown Cancer Center

Moderator: Philip Schwieterman, PharmD, MHA

1:00 – 1:45 p.m. ET

Breakout Session 2

Genetics, Genomics, and Multidisciplinary Care

Speakers

Terra Armstrong, MS, LGC
Licensed Genetic Counselor
Genetic Counselor Supervisor
UK Markey Cancer Center

Bryan Brinda, PharmD, BCOP
Pharmacist Program Coordinator, Precision Medicine & Clinical Research
UK Markey Cancer Center

Moderator: Allison Butts, PharmD

1:45 – 2:30 p.m. ET

Breakout Session 3

Primary Hemophagocytic Lymphohistiocytosis: A Review in Management

Speaker
Chris Cornett, PharmD
Hematology Oncology Clinical Pharmacist Specialist
Baptist Health Louisville

Moderator: Philip Schwieterman, PharmD, MHA

1:45 – 2:30 p.m. ET

Breakout Session 4

Automation to Augmentation: AI in Oncology Care

Speaker
Janeesh Sekkath Veedu, MD, FACP
Medical Oncologist
UK Markey Cancer Center

Moderator: Josh O'Bryan, PharmD

2:30 – 2:45 p.m. ET

Break & Visit Exhibitors

2:45 – 3:30 p.m. ET

General Session 5

Managing Biosimilars in a Dynamic Landscape

Speakers

Rachael Morgan, PharmD, BCOP
Hematology Oncology Pharmacy Research and Formulary Manager
UK Markey Cancer Center

Becky Champion, PharmD, MS, BCOP
Director of Pharmacy Services
Norton Cancer Institute

Danielle Otto, PharmD, BCOP
Evolent

Anna E. Hitron, PharmD, MS, MBA, BCOP
Pharmacy Clinical Manager
Baptist Health Louisville

Moderator: Philip Schwieterman, PharmD, MHA

3:30 – 3:45 p.m. ET

Closing Remarks & Adjourn

Moderator: Allison Butts, PharmD

University of Kentucky Gatton Student Center
160 Avenue of Champions
Lexington, KY 40508
United States
Moderator(s)

Philip Schwieterman

has no relevant financial relationships to disclose at this time.
Planner(s)

Timothy Mullett, MD, MBA, FACS

has no relevant financial relationships to disclose at this time.

Susan Reffett, MSN, RN, CNOR

has no relevant financial relationships to disclose at this time.

Philip Schwieterman

has no relevant financial relationships to disclose at this time.
Speaker(s)

Terra Armstrong

has no relevant financial relationships to disclose at this time.

Bryan Brinda

has no relevant financial relationships to disclose at this time.

Becky Champion

has no relevant financial relationships to disclose at this time.

Amy Dawson

has no relevant financial relationships to disclose at this time.

Anna Hitron

has no relevant financial relationships to disclose at this time.

Rachel Miller, MS, RD, CSO, LD

has no relevant financial relationships to disclose at this time.

Timothy Mok

has no relevant financial relationships to disclose at this time.

Rachael Morgan

has no relevant financial relationships to disclose at this time.

Kristina Naseman, PharmD, MPH, BCACP, BC-ADM, CDCES

has no relevant financial relationships to disclose at this time.

Logan Roberts

has no relevant financial relationships to disclose at this time.

Available Credit

  • 5.25 ACPE

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    This knowledge-based activity will award 5.25 contact hour(s) (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers. Course JA-UAN Number:

  • 5.25 AMA PRA Category 1 Credit™

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    This Live activity is designated for a maximum of 5.25 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity. 

  • 5.25 AMA PRA Category 1 Credit™ Participation

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    This Live activity is designated for a maximum of 5.25 AMA PRA Category 1 Credit™ Participation. Learners should claim only credit commensurate with the extent of their participation in the activity.

  • 5.25 ANCC (UK Healthcare CECentral)

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    The maximum number of hours awarded for this Continuing Nursing Education activity is 5.25 nursing contact hour(s).

  • 5.25 IPCE

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    This activity was planned by and for the healthcare team, and learners will receive 5.25 Interprofessional Continuing Education (IPCE) credit(s) for learning and change.

Please login or register to take this course.

After registering, the Attendance tab will appear. Please disregard the Attendance screen at this time; this step will be completed after you attend the conference.

You must attend the conference to receive the attendance code and instructions for claiming credit. Return only after you have attended the conference. The attendance code will be included in the credit instructions for claiming credit.